Evaluating Explanations of an Alzheimer's Disease 18F-FDG Brain PET Black-Box Classifier

被引:0
|
作者
De Santi, Lisa Anita [1 ,2 ]
Bargagna, Filippo [1 ,2 ]
Santarelli, Maria Filomena [3 ]
Positano, Vincenzo [1 ,2 ]
机构
[1] Univ Pisa, Dept Informat Engn, Pisa, Italy
[2] Fdn G Monasterio CNR Reg Toscana, UOC Bioingn, Pisa, Italy
[3] CNR Inst Clin Physiol, Pisa, Italy
关键词
Medical Imaging; Black-box DL; Posthoc Explanations; Attribution Maps; Latent Space Interpretation; Evaluating XAI; DIAGNOSIS; DEMENTIA;
D O I
10.1007/978-3-031-44064-9_30
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
eXplainable Artificial Intelligence (XAI) has been increasingly applied to interpret Deep Neural Networks (DNN) in medical imaging applications, but a general consensus about the best interpretation strategy is missing. This is also due to the absence of a validated framework to assess the quality of the explanations/interpretations produced by different XAI methods. This work aims to quantify the ability of interpretation techniques of producing good explanations and non-misleading representations of what a black-box model has learned. We selected a DNN which classifies 18F-FDG PET images according to the cognitive decline in Alzheimer's disease, and we applied two different interpretability methods commonly employed in bioimaging: attribution maps (Backpropagation, GradCAM++, Layerwise Relevance Propagation), and latent space interpretation (t-SNE, UMAP, TriMAP, PaCMAP). We evaluated the interpretations using different literature frameworks: evaluation of attribution maps with imaging biomarkers and region perturbation, and preservation of data local and global structure of the latent space. Results suggested that we are not able to observe a clear relationship between the PET signal and attribution maps, highlighting the importance of not assuming that XAI explanations should reflect the human's reasoning. Layerwise Relevance Propagation best explains the classifier's decisions according to the region-perturbation evaluation, confirming literature results. Finally, the UMAP and the TriMAP embedding respectively reported the best result for the preservation of the local and the global data structure, which is, to the best of our knowledge, the first systematic assessment in the medical imaging domain, and in line with theoretical background of the methods employed.
引用
收藏
页码:558 / 581
页数:24
相关论文
共 50 条
  • [41] Initial Clinical Comparison of 18F-Florbetapir and 18F-FDG PET in Patients with Alzheimer Disease and Controls
    Newberg, Andrew B.
    Arnold, Steven E.
    Wintering, Nancy
    Rovner, Barry W.
    Alavi, Abass
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 902 - 907
  • [42] Comparison of 18F-FET and 18F-FDG PET in brain tumors
    Pauleit, Dirk
    Stoffels, Gabriele
    Bachofner, Ansgar
    Floeth, Frank W.
    Sabel, Michael
    Herzog, Hans
    Tellmann, Lutz
    Jansen, Paul
    Reifenberger, Guido
    Hamacher, Kurt
    Coenen, Heinz H.
    Langen, Karl-Josef
    NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (07) : 779 - 787
  • [43] Abdominal Castleman's disease with 18F-FDG PET-CT
    Romero, A. Badenes
    Lopez, M. Mila
    Vallansot, R. Omar
    Murcia, C. A. Achury
    Alanis, M. P. Fierro
    Salazar, D. Carrera
    Muro, V. Izquierdo
    Caicedo, L. M. Quintero
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (06): : 418 - 419
  • [44] 18F-FDG PET/CT imaging in the diagnosis of Parkinson's disease
    Mao, Z.
    Ji, S.
    Yang, Q.
    Ye, H.
    Xue, Z.
    MOVEMENT DISORDERS, 2015, 30 : S18 - S18
  • [45] 18F-FDG PET/CT in Metastatic Extramammary Paget's Disease
    Khoo, Alex Cheen Hoe
    Yeoh, Kheng Wei
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (10) : 808 - 809
  • [46] 18F-FDG PET/CT: an unexpected case of Huntington's disease
    Michels, Sebastian
    Buchholz, Hans-Georg
    Rosar, Florian
    Heinrich, Isabel
    Hoffmann, Manuela A.
    Schweiger, Susann
    Tuescher, Oliver
    Schreckenberger, Mathias
    BMC NEUROLOGY, 2019, 19 (1)
  • [47] 18F-FDG PET/CT: an unexpected case of Huntington’s disease
    Sebastian Michels
    Hans-Georg Buchholz
    Florian Rosar
    Isabel Heinrich
    Manuela A. Hoffmann
    Susann Schweiger
    Oliver Tüscher
    Mathias Schreckenberger
    BMC Neurology, 19
  • [48] Role of 18F-FDG PET for evaluating malignant pleural mesothelioma
    Nanni, C
    Castellucci, P
    Farsad, M
    Pinto, C
    Moretti, A
    Pettinato, C
    Marengo, M
    Boschi, S
    Franchi, R
    Martoni, A
    Monetti, N
    Fanti, S
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (02) : 149 - 154
  • [49] 18F-FDG-PET in Mouse Models of Alzheimer's Disease
    Bouter, Caroline
    Bouter, Yvonne
    FRONTIERS IN MEDICINE, 2019, 6
  • [50] 18F-FDG PET and PET/CT in Burkitt's lymphoma
    Karantanis, Dimitrios
    Durski, Jolanta M.
    Lowe, Val J.
    Nathan, Mark A.
    Mullan, Brian P.
    Georgiou, Evangelos
    Johnston, Patrick B.
    Wiseman, Gregory A.
    EUROPEAN JOURNAL OF RADIOLOGY, 2010, 75 (01) : E68 - E73